Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SKYE compared with TRDA: revenue, margins and what each company keeps, and the suppliers and customers both name
SKYE
Skye Bioscience, Inc.
Change
Mkt cap
Revenue
Revenue
TRDA
Entrada Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SKYE
Skye Bioscience, Inc.
vs
TRDA
Entrada Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SKYE, solid
TRDA, dashed
SKYE
Skye Bioscience, Inc.
Change
1.09
▲
+4.37%
· post 1.00
Mkt cap
$4.4M
Revenue
—
Revenue
—
TRDA
Entrada Therapeutics, Inc.
Change
4.86
▲
+6.91%
· post 4.87
Closed
Nov 6 '26
Mkt cap
$191.4M
Revenue
$905,000
Q3 FY26
Revenue
$25M
FY25
vs
Compare
Closed
Nov 6 '26
SKYE
Skye Bioscience, Inc.
vs
TRDA
Entrada Therapeutics, Inc.
1.09
▲
+4.37%
post 1.00
Price
4.86
▲
+6.91%
post 4.87
$4.4M
Mkt cap
$191.4M
—
Revenue
$905,000
Q3 FY26
—
Revenue
$25M
FY25
Change
Change
SKYE
1.09
▲
+4.37%
vs
TRDA
4.86
▲
+6.91%
Closed
Nov 6 '26